Cargando…
Drug transporters: recent advances concerning BCRP and tyrosine kinase inhibitors
Multidrug resistance is often associated with the (over)expression of drug efflux transporters of the ATP-binding cassette (ABC) protein family. This minireview discusses the role of one selected ABC-transporter family member, the breast cancer resistance protein (BCRP/ABCG2), in the (pre)clinical e...
Autores principales: | Lemos, C, Jansen, G, Peters, G J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2266858/ https://www.ncbi.nlm.nih.gov/pubmed/18253130 http://dx.doi.org/10.1038/sj.bjc.6604213 |
Ejemplares similares
-
Predictive indicators of successful tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia
por: Stuckey, Ruth, et al.
Publicado: (2020) -
Tyrosine kinase inhibitors and human epidermal growth factor receptor-2 positive breast cancer
por: Abunada, Aya, et al.
Publicado: (2023) -
Recent advances in the search of BCRP- and dual P-gp/BCRP-based multidrug resistance modulators
por: Dei, Silvia, et al.
Publicado: (2019) -
Negative regulation of ErbB family receptor tyrosine kinases
por: Sweeney, C, et al.
Publicado: (2004) -
Current understanding of the role of tyrosine kinase 2 signaling in immune responses
por: Muromoto, Ryuta, et al.
Publicado: (2022)